Leah Price

Title: Innovations in ALS Treatment: The Impact of Inventor Leah Price

Introduction

Leah Price, a dedicated inventor based in Karmiel, Israel, has made significant strides in the field of medical innovation. With one patent to her name, she is recognized for her contributions to the treatment of Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that affects motor function.

Latest Patents

Leah Price's patent focuses on treatment methods for ALS patients. Specifically, it provides innovative methods and compositions that utilize chlorite or pharmaceutical compositions containing sodium chlorite aimed at a target ALS patient population. The patent also outlines methods for identifying ALS patients who are likely to respond favorably to chlorite treatments, including those with elevated plasma C-reactive protein (CRP) levels, ages 40 to 65, and sporadic ALS pathology.

Career Highlights

Throughout her career, Leah has worked with reputable organizations, including Neuvivo, Inc. and the University of California. Her roles in these institutions have allowed her to collaborate on impactful research aimed at improving patient outcomes and advancing scientific knowledge in the field of ALS treatment.

Collaborations

One of Leah's notable collaborations has been with her coworker, Michael S. McGrath. This partnership underscores the importance of teamwork in the research and development process, as they work together to address the challenges faced by ALS patients and develop effective treatment options.

Conclusion

Leah Price exemplifies the spirit of innovation in medicine, pushing the boundaries of what is possible in the field of ALS treatment. Her patented methods represent a promising step forward in the quest for effective therapies, highlighting the critical role inventors play in shaping the future of healthcare.